Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Novasep Appoints President and CEO

Published: Thursday, June 27, 2013
Last Updated: Thursday, June 27, 2013
Bookmark and Share
Novasep announces the appointment of Michel Spagnol as President and CEO of the company, effective from 25 June 2013.

He will succeed Patrick Glaser, who after three years at Novasep in France, has decided to return to the USA. Michel Spagnol joins Novasep from Shasun, where he was President and Chief Technology Officer. He is a proven business leader with core expertise in leading contract manufacturing of active pharmaceutical ingredients and, more broadly, strong experience in using and developing innovative technologies to address needs of customers in fine chemicals and life sciences fields. Prior to Shasun Michel Spagnol spent his career at Rhodia in Lyon and Cranbury (NJ, USA) where he progressed first in technical R&D leadership roles and subsequently transitioned to business development as a Sales and Marketing Vice President of Rhodia Pharma Solutions.

Over the past months Novasep’s growth has gained momentum with significant new investments in Mourenx (France), to build the world’s largest chromatography plant dedicated to the pharmaceutical industry, in Le Mans (France) to expand manufacturing capabilities of cutting-edge anti-cancer therapies and in Shanghai (China) to better serve its clients in Asia. Roger-Marc Nicoud, Founder and Non-Executive Chairman of the Board of Novasep, said: “We are delighted to welcome Michel Spagnol to Novasep as CEO.His track record in delivering customer driven solutions, his international and scientific background coupled with his extensive management experience and longstanding knowledge and relationships in the pharmaceutical industry will be strong assets for the Company. He has all the qualities required to consolidate and accelerate Novasep’s development. On behalf of the Board, I would like to thank Patrick Glaser for his contributions as the CEO of the Company and accomplishments as Head of Novasep Synthesis. Over the past years, Novasep has grown significantly under his leadership, and he has developed a solid foundation for Michel Spagnol to build upon.”

Michel Spagnol, new CEO, declared: “Novasep is a world leader in purification technologies with differentiated capabilities in hazardous chemistry and high potency chemistry and is well positioned to serve the pharmaceutical, fine chemical, bio-pharma and industrial biotech industries. I am very pleased to be given the opportunity to lead the Company. I am looking forward to working closely with all my new colleagues. Novasep is on the right track for continued growth and expansion with promising projects which will enable us to continue delivering value-added solutions for our global customers.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Novasep and instrAction Enter into a Worldwide Strategic Alliance for Non-Chiral Chromatography
Combination of instrAction and Novasep know-how sets a new standard for small molecule purification processes for the life science industries.
Tuesday, July 20, 2010
Novasep Acquires Bioprocess Development Specialist and Contract Manufacturer Henogen
Acquisition of upstream processing capabilities and services enables Novasep to offer full-range of biomanufacturing solutions.
Wednesday, July 08, 2009
Scientific News
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
New Diabetes Drug has Unexpected Side Effect
A type of drug used to treat diabetes may reduce the risk of developing Parkinson’s disease, according to new research.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Cannabis May Be Used to Treat Fractures
TAU researcher finds non-psychotropic compound in marijuana can help heal bone fissures.
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Creating More Potent Vaccines
Yale researchers uncovered a new role for a type of immune cell, known as regulatory T cells, in promoting long-term immunity.
Potential Therapeutic for Blinding Eye Disease
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Global Search for Next Antibiotic
University of Queensland researchers have launched a global search to discover antibiotics capable of combating superbug bacteria that are resistant to current antibiotics.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!